Abstract 189: Evaluation of Atrial Fibrillation Outcomes in Heart Failure Patients Taking Sacubitril/valsartan or Ivabradine
2019
Background: Approximately 5.7 million adults have heart failure in the United States. No pharmacological breakthrough molecules have been developed for heart failure patients since angiotensin conv...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI